The global dermal fillers market size is expected to reach USD 14.19 billion by 2033, registering a CAGR of 10.9% from 2026 to 2033, according to a new report by Grand View Research, Inc. Dermal fillers are soft tissue injectables that are injected into different depths of the skin and assist in treating signs of aging, loss of volume, facial contouring, etc. The ever-rising demand for aesthetic treatments that are safe and effective, increasing focus on appearance, rising disposable income, and growing geriatric population are expected to boost the market growth. As per the American Society of Plastic Surgeons, dermal fillers differ in chemical makeup and longevity and have varying degrees of softness.
For example, softer fillers are used on the lips, while sturdier fillers areused to enhance cheekbones. The ASPS reported that in 2020, around 2,619,650 hyaluronic acid dermal filler treatments were carried out in the U.S, and brands like Juvederm Ultra, Juvederm Ultra Plus, Perlane, Restylane, Belotero were the most preferred.The product demand is expected to increase significantly due to the fact that it provides desired results for individuals and can also be reversed if the patient is not satisfied with the results.
Growing social media influence, high consciousness about aesthetic appearance, and its association with self-confidence and self-image by an individual are some of the factors driving the market growth.In light of COVID-19, the market was hampered as the footfall of patient appointments for aesthetic treatments was temporarily suspended during the first half of 2020. However, the demand has been on the rise post-pandemic. Moreover, according to the BBC network, inquiries and appointments for many surgical and non-surgical cosmetic treatments have seen a surge following the pandemic and are thus expected to boost the market growth.
Request a free sample copy or view report summary: Dermal Fillers Market Report
By product, the hyaluronic acid segment dominated the market in 2025 and accounted for the largest share of 78.4% of the overall revenue. The PN/PDRN segment is expected to witness the fastest CAGR over the forecast period.
By application, the wrinkle correction segment dominated the market and held the largest revenue share of 31.8% in 2025. The lip augmentation segment is expected to witness the fastest CAGR over the forecast period.
By end-use, the aesthetic surgery centers segment dominated the industry and held the largest revenue share of 42.9% in 2025. The medSpas segment is anticipated to grow at the fastest CAGR of 11.5% over the forecast period.
North America's dermal fillers market accounted for the largest revenue share of 38.5% in 2025. Dermal fillers market in the U.S. is experiencing steady growth, driven by strong physician networks, surgeon/dermatologist procedural volumes, and rapid incorporation of new, indication-specific HA products into practice.
Grand View Research has segmented global dermal fillers market report based on product, application, end-use, and region:
Dermal Fillers Product Outlook (Revenue, USD Million, 2021 - 2033)
Hyaluronic Acid
Monophasic
Biphasic
Calcium Hydroxylapatite
Polylactic Acid (PLLA)
Collagen and PMMA Microspheres
PCL
PN/PDRN
Dermal Fillers Application Outlook (Revenue, USD Million, 2021 - 2033)
Wrinkle Correction
Facial Contouring
Scar Treatment
Lip Augmentation
Volume Loss Restoration
Others
Dermal Fillers End-use Outlook (Revenue, USD Million, 2021 - 2033)
MedSpa
Aesthetic Surgery Centers
Hospitals
Others
Dermal Fillers Region Outlook (Revenue, USD Million, 2021 - 2033)
North America
U.S.
Canada
Europe
UK
Germany
France
Italy
Spain
Norway
Denmark
Sweden
Russia
Asia Pacific
China
Japan
South Korea
Thailand
Australia
Singapore
Malaysia
Taiwan
India
Vietnam
Philippines
Latin America
Brazil
Argentina
Mexico
MEA
South Africa
Saudi Arabia
UAE
Kuwait
List of Key Players of Dermal Fillers Market
AbbVie
Galderma
Merz Pharma
Sinclair Pharma
Revance
Teoxane
Laboratories Vivacy
IBSA Farmaceutici Italia Srl
Hugel
Across Co.
BioPlus Co.
LG Chem
Medytox
Caregen
Prollenium Medical
Evolus
Daewoong Pharmaceutical
Koru Pharmaceuticals
Tiger Aesthetics Medical (Suneva Medical)
"The quality of research they have done for us has been excellent..."